July 22, 2016 — The FDA has announced a recall for a common over-the-counter liquid stool softener after it was linked to an infection outbreak.
Diocto Liquid was sold under the Rugby® brand-name by PharmaTech, LLC in 1-pint (437 mL) bottles. It was recalled after B. cepacia was found in an unopened bottle.
The CDC has confirmed 49 infections in 5 states among patients who were given Diocto Liquid or other stool softeners that contain docusate sodium.
The FDA warns patients and doctors not to use any liquid docusate sodium stool softeners for any purpose.
Health officials are investigating additional cases, primarily among very sick patients on ventilators who were being treated in intensive care units.
Burkholderia cepacia (also known as “B. cepacia complex”) is a bacteria that is commonly found in soil and water. It is resistant to many antibiotics. The symptoms of infection vary widely, ranging from no symptoms at all to severe respiratory disease.
Transmission can occur through person-to-person contact, contaminated surfaces or medical devices, and exposure to B. cepacia in the environment. It often occurs in patients with vulnerable immune systems, especially patients with chronic lung diseases like cystic fibrosis.
Do I have a Diocto Infection Lawsuit?
The Schmidt Firm, PLLC is currently accepting Diocto Liquid stool softener induced injury cases in all 50 states. If you or somebody you know has been diagnosed with a B. cepacia infection, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.